Neuronetics, Inc. (STIM) Debt / Equity
- 2024-06-30: Debt/Equity Ratio 3.08.
- 2022-12-31: Debt/Equity Ratio 0.63.
- 2022-09-30: Debt/Equity Ratio 0.57.
- 2022-06-30: Debt/Equity Ratio 0.52.
Complete source-backed debt/equity ratio history.
- Available history
- 2017-12-31 to 2024-06-30
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2024-06-30 | 3.08 |
| 2022-12-31 | 0.63 |
| 2022-09-30 | 0.57 |
| 2022-06-30 | 0.52 |
| 2021-09-30 | 0.77 |
| 2020-09-30 | 2.51 |
| 2020-06-30 | 2.34 |
| 2019-12-31 | 0.65 |
| 2019-09-30 | 0.57 |
| 2019-06-30 | 0.51 |
| 2018-09-30 | 0.4 |
| 2018-06-30 | -0.15 |
| 2017-12-31 | -0.15 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2022-12-31 | 0.63 |
| 2019-12-31 | 0.65 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |